[go: up one dir, main page]

AU2003261460A1 - Single nucleotide polymorphisms diagnostic for schizophrenia - Google Patents

Single nucleotide polymorphisms diagnostic for schizophrenia

Info

Publication number
AU2003261460A1
AU2003261460A1 AU2003261460A AU2003261460A AU2003261460A1 AU 2003261460 A1 AU2003261460 A1 AU 2003261460A1 AU 2003261460 A AU2003261460 A AU 2003261460A AU 2003261460 A AU2003261460 A AU 2003261460A AU 2003261460 A1 AU2003261460 A1 AU 2003261460A1
Authority
AU
Australia
Prior art keywords
schizophrenia
single nucleotide
nucleotide polymorphisms
diagnostic
polymorphisms diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261460A
Other languages
English (en)
Other versions
AU2003261460A8 (en
Inventor
Paul S. Kaytes
Chi-Hse Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/230,007 external-priority patent/US20030170667A1/en
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2003261460A8 publication Critical patent/AU2003261460A8/xx
Publication of AU2003261460A1 publication Critical patent/AU2003261460A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003261460A 2002-08-28 2003-08-26 Single nucleotide polymorphisms diagnostic for schizophrenia Abandoned AU2003261460A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40643202P 2002-08-28 2002-08-28
US60/406,432 2002-08-28
US10/230,007 US20030170667A1 (en) 2001-08-28 2002-08-28 Single nucleotide polymorphisms diagnostic for schizophrenia
US10/230,007 2002-08-28
PCT/US2003/024799 WO2004020580A2 (fr) 2002-08-28 2003-08-26 Diagnostic unique des polymorphismes nucleotidiques predestinant a la schizophrenie

Publications (2)

Publication Number Publication Date
AU2003261460A8 AU2003261460A8 (en) 2004-03-19
AU2003261460A1 true AU2003261460A1 (en) 2004-03-19

Family

ID=31980950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261460A Abandoned AU2003261460A1 (en) 2002-08-28 2003-08-26 Single nucleotide polymorphisms diagnostic for schizophrenia

Country Status (4)

Country Link
EP (1) EP1546398A4 (fr)
JP (1) JP2005537010A (fr)
AU (1) AU2003261460A1 (fr)
WO (1) WO2004020580A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006023719A2 (fr) * 2004-08-20 2006-03-02 Enh Research Institute Mutation genetique indiquant un risque accru de schizophrenie, de trouble schizo-affectif et de trouble bipolaire et applications pour le diagnostic et le traitement de ces maladies
US7932042B1 (en) 2010-10-13 2011-04-26 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1237909A2 (fr) * 1999-11-16 2002-09-11 PHARMACIA & UPJOHN COMPANY Recepteurs couples a une proteine g
WO2002064789A1 (fr) * 2001-02-14 2002-08-22 Pharmacia & Upjohn Company Recepteur couple aux proteines
US20030170667A1 (en) * 2001-08-28 2003-09-11 Kaytes Paul S. Single nucleotide polymorphisms diagnostic for schizophrenia

Also Published As

Publication number Publication date
WO2004020580A2 (fr) 2004-03-11
AU2003261460A8 (en) 2004-03-19
WO2004020580A8 (fr) 2004-07-08
EP1546398A2 (fr) 2005-06-29
JP2005537010A (ja) 2005-12-08
WO2004020580A3 (fr) 2005-04-14
EP1546398A4 (fr) 2006-10-18

Similar Documents

Publication Publication Date Title
AU2003259350A1 (en) Modified nucleotides for polynucleotide sequencing
AU2003237588A1 (en) Piston-actuated endoscopic steering system
AU2003212708A1 (en) Baculovirus expression system
AU2002353543A1 (en) Biosensor
AU2003266227A1 (en) Crossmember
EP1695251B8 (fr) Outil clinique de localisation de structures
AU2003901671A0 (en) Comparative genomic hybridization
AU2002952938A0 (en) System for Conducting Clinical Trials
AU2003249846A1 (en) Bus
AU2002321851A1 (en) Novel linker for nucleotides
AU2002307172A1 (en) Haplotyping method for multiple distal nucleotide polymorphisms
AU2003250080A1 (en) Oligonucleotides for detecting micro-organisms
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU2002324711A1 (en) Single nucleotide polymorphisms diagnostic for schizophrenia
AU2003299867A1 (en) Method for single nucleotide polymorphism detection
WO2004020580A3 (fr) Diagnostic unique des polymorphismes nucleotidiques predestinant a la schizophrenie
AU2001277997A1 (en) Diagnostic polymorphisms for the tgf-beta1 promoter
AU2003222965A1 (en) Schizophrenia associated genes
AU2003251424A1 (en) Electrochemical detection of single nucleotide polymorphisms (snps)
AU2003210259A1 (en) Method for detecting single nucleotide polymorphisms
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU2003271889A1 (en) Hydrosilation catalyst
GB0229139D0 (en) Gene polymorphisms
AU2002366709A1 (en) Nucleotide polymorphisms associated with osteoporosis
AU2003238501A1 (en) Hybridization chamber

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase